Nanoform Finland Oyj (FRA:4YL)

Germany · Delayed Price · Currency is EUR

0.7250

-0.0160 (-2.16%)

Last updated: Feb 23, 2026, 8:22 AM CET

Revenue by Segment

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Expert Services in Nanotechnology and Drug Particle Engineering	3.66M	2.57M	3.49M	1.95M	702.12K
Expert Services in Nanotechnology and Drug Particle Engineering Growth	42.70%	-26.41%	78.42%	178.38%	150.37%
Total	3.66M	2.57M	3.49M	1.95M	702.12K
Total Growth	42.70%	-26.41%	78.42%	178.38%	150.37%

Revenue by Geography

Financials in millions EUR. Fiscal year is January - December.

Millions EUR. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017
Europe	1.89M	1.46M	1.96M	1.56M	546.83K
Europe Growth	29.17%	-25.37%	25.90%	184.88%	3519.93%
United States	791.05K	1.10M	1.53M	396.77K	139.92K
United States Growth	-28.27%	-27.73%	284.63%	183.57%	311.68%
Other	95.89K	-	-	-	-
Total	2.78M	2.57M	3.49M	1.95M	686.75K
Total Growth	8.22%	-26.41%	78.42%	184.61%	1298.84%

Source: S&P Global Market Intelligence.